Arxx Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A First in Human Study of AX-202 in Healthy Subjects and Patients With Psoriasis. (NCT05965089) | Arxx Therapeutics | 2023-04-25 |
Track Arxx Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.